Clinical trial
Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With…
NCT00397670 · ReProtect Inc, Industry · Completed
Key facts
| NCT number | NCT00397670 |
|---|---|
| Title | Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm |
| Official title | A Multicenter Open-Label Study of the Safety and Contraceptive Efficacy of BufferGel® Spermicide Used With Diaphragm |
| Lead sponsor | ReProtect Inc, Industry |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH Premier Research |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Drug: BufferGel® with diaphragm |
| Enrollment | 200 |
| Start date | Jan 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Nov 9, 2006 |
| Last update posted | Nov 9, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: